| 5-FU | 5-fluorouracil |
| CI | confidence interval |
| CPS | combined positive score |
| CT | computed tomography |
| CTCAE | Common Terminology Criteria for Adverse Events |
| CTV | clinical target volume |
| GTV | gross tumor volume |
| HR | hazard ratio |
| IMRT | intensity-modulated radiation therapy |
| IQR | interquartile range |
| nCRT | neoadjuvant chemoradiotherapy |
| OAR | organs at risk |
| OS | overall survival |
| pCR | pathological complete response |
| PET/CT | positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography |
| pN+ | pathological residual node disease |
| pT+ | pathological residual primary disease |
| PTV | planning target volume |
| SAD | source–axis distance |
| SCC | squamous cell carcinoma |
| SOC | standard of care |
| SUVmax | maximum standardized uptake value |
| TNM | Tumor-node-metastasis |
| TRG | tumor regression grade |